Interim Buprenorphine Treatment

Interim Buprenorphine Treatment (IBT) is a technology-assisted pharmacological and behavioral intervention developed by researchers at the University of Vermont to address treatment waitlist delays for individuals with opioid use disorder (OUD). The protocol utilizes buprenorphine (typically in combination with naloxone), a partial mu-opioid receptor agonist, as the primary medication. IBT incorporates computerized medication dispensing devices for at-home use and an Interactive Voice Response (IVR) system for daily monitoring and random call-backs, allowing for reduced in-person clinic visits (e.g., bi-monthly instead of daily). This approach is specifically designed to provide immediate stabilization for patients in rural or underserved areas where traditional comprehensive treatment capacity is limited, bridging the gap until they can enter a standard treatment program.

Other names

Interim Buprenorphine Treatment for Opioid Use DisorderIBT protocol